Unissued shares As at the date of this report, unissued ordinary shares under share based payment arrangements are: Performance Rights (Rights) Number of shares Exercise Price Expiry Date Rights – Tranche 6 - Directors 323,596 Zero 1 October 2025 Rights – Tranche 6 - Employees 1,228,152 Zero 1 October 2025 Rights – Tranche 7 - Directors 760,541 Zero 1 October 2026 Rights – Tranche 7 - Employees 4,144,457 Zero 1 October 2026 Rights – Tranche 8 - Directors 500,483 Zero 30 June 2029 Rights – Tranche 8 - Employees 3,686,757 Zero 30 June 2029 Total 10,643,986 Holders of these instruments do not have any right, by virtue of the instrument, to participate in any share issue of the Company or any related body corporate. Shares issued as a result of exercising performance rights During the financial year 580,527 listed rights were converted to acquire fully paid ordinary shares in the Company, refer to Note 24 for further details. INDEMNIFICATION AND INSURANCE OF DIRECTORS AND OFFICERS During the financial year, the Company paid a premium in respect of a contract of insurance to insure Directors and Officers of the Company and related bodies corporate against those liabilities for which insurance is permitted under section 199B of the Corporations Act 2001. Disclosure of the nature of the liabilities and the amount of the premium is prohibited under the conditions of the contract of insurance. INDEMNIFICATION OF AUDITORS To the extent permitted by law, the Company has agreed to indemnify its auditors, Deloitte Touche Tohmatsu , as part of the terms of its audit engagement agreement against claims by third parties arising from the audit (for an unspecified amount). No payment has been made to indemnify Deloitte Touche Tohmatsu during or since the financial year. 53 ANNUAL REPORT 2025
RkJQdWJsaXNoZXIy MjE2NDg3